πŸ‡ΊπŸ‡Έ FDA
Patent

US 9371383

Anti-ASIC1 antibodies and uses thereof

granted A61KA61K2039/505

Quick answer

US patent 9371383 (Anti-ASIC1 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505